This plan amendment adds establishes a cost-based reimbursement methodology for NC Select Drugs, including Cell and Gene Therapies administered in the Hospital Inpatient, Hospital Outpatient, and Professional Outpatient settings.
State
North Carolina
Topics
Reimbursement
Approval Date
Effective Date
File 1 - Approval Document Media